PD-L1 an unavoidable biomarker in advanced triple-negative breast cancer.

PD-L1 an unavoidable biomarker in advanced triple-negative breast cancer. Biomark Med. 2019 Oct 21;: Authors: Akiki M, Haddad FG, Kourie HR, Khaddage A, Smayra VT PMID: 31631684 [PubMed - as supplied by publisher]
Source: Future Medicine: Biomarkers in Medicine - Category: Internal Medicine Tags: Biomark Med Source Type: research